MedTrace Logo

Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males

NCT01067391 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-07-17

No results posted yet for this study

Summary

To address the effect of tadalafil (Cialis) on the cardiovascular system of men with complete spinal cord injury at T-6 and above. The hypothesis is that tadalafil will cause significant hypotension in people with tetraplegia.

Conditions

Interventions

DRUG

tadalafil

20 mg tablet, administered once per study protocol

DRUG

placebo

placebo tablet administered once per study protocol

Sponsors & Collaborators

  • Manitoba Medical Service Foundation

    collaborator OTHER

  • Rick Hansen Foundation

    collaborator OTHER

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Karen D. Ethans, MD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067391 on ClinicalTrials.gov